Concept domain validation and item generation for the Treatment-Induced Neuropathy Assessment Scale (TNAS)

A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphoma

(2016) Eunhye Oak et al.   Expert Opinion On Drug Safety

The trajectory of neurotoxic side effects’ impact on daily life: a qualitative study

(2016) Jenny Drott et al.   SUPPORTIVE CARE IN CANCER

Concept Elicitation Within Patient-Powered Research Networks: A Feasibility Study in Chronic Lymphocytic Leukemia

(2016) Kelly P. McCarrier et al.   VALUE IN HEALTH

The double-edged sword: Neurotoxicity of chemotherapy

(2015) Rajiv S. Magge et al.   BLOOD REVIEWS

Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale

(2015) Tito R. Mendoza et al.   JOURNAL OF PAIN

Development of the National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

(2014) E. Basch et al.   JNCI-Journal of the National Cancer Institute

Late effects of oxaliplatin-induced peripheral neuropathy (LEON)—cross-sectional cohort study of patients with colorectal cancer surviving at least 2 years

(2014) Sunita Padman et al.   SUPPORTIVE CARE IN CANCER

Capturing the Patient's Experience: Using Qualitative Methods to Develop a Measure of Patient-Reported Symptom Burden: An Example From Ovarian Cancer

(2013) Loretta A. Williams et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

International development of an EORTC questionnaire for assessing health-related quality of life in chronic myeloid leukemia patients: the EORTC QLQ-CML24

(2013) Fabio Efficace et al.   QUALITY OF LIFE RESEARCH

ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research

(2013) Bryce B. Reeve et al.   QUALITY OF LIFE RESEARCH

The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA

(2012) Sherry L. Wolf et al.   SUPPORTIVE CARE IN CANCER

Impact of oxaliplatin-induced neuropathy: a patient perspective

(2012) Barbara K. Bennett et al.   SUPPORTIVE CARE IN CANCER

Comparison of 7-Day Recall and Daily Diary Reports of COPD Symptoms and Impacts

(2012) Antonia V. Bennett et al.   VALUE IN HEALTH

Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument

(2011) Donald L. Patrick et al.   VALUE IN HEALTH

Use of Existing Patient-Reported Outcome (PRO) Instruments and Their Modification: The ISPOR Good Research Practices for Evaluating and Documenting Content Validity for the Use of Existing Instruments and Their Modification PRO Task Force Report

(2009) Margaret Rothman et al.   VALUE IN HEALTH